Fcγ receptors : genetic variation, function, and disease
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd..
Fcγ receptors (FcγRs) are key immune receptors responsible for the effective control of both humoral and innate immunity and are central to maintaining the balance between generating appropriate responses to infection and preventing autoimmunity. When this balance is lost, pathology results in increased susceptibility to cancer, autoimmunity, and infection. In contrast, optimal FcγR engagement facilitates effective disease resolution and response to monoclonal antibody immunotherapy. The underlying genetics of the FcγR gene family are a central component of this careful balance. Complex in humans and generated through ancestral duplication events, here we review the evolution of the gene family in mammals, the potential importance of copy number, and functionally relevant single nucleotide polymorphisms, as well as discussing current approaches and limitations when exploring genetic variation in this region.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:268 |
|---|---|
| Enthalten in: |
Immunological reviews - 268(2015), 1 vom: 24. Nov., Seite 6-24 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hargreaves, Chantal E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies |
|---|
| Anmerkungen: |
Date Completed 19.08.2016 Date Revised 27.10.2015 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1111/imr.12341 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM253978890 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM253978890 | ||
| 003 | DE-627 | ||
| 005 | 20231224171401.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/imr.12341 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0846.xml |
| 035 | |a (DE-627)NLM253978890 | ||
| 035 | |a (NLM)26497510 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hargreaves, Chantal E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Fcγ receptors |b genetic variation, function, and disease |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.08.2016 | ||
| 500 | |a Date Revised 27.10.2015 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. | ||
| 520 | |a Fcγ receptors (FcγRs) are key immune receptors responsible for the effective control of both humoral and innate immunity and are central to maintaining the balance between generating appropriate responses to infection and preventing autoimmunity. When this balance is lost, pathology results in increased susceptibility to cancer, autoimmunity, and infection. In contrast, optimal FcγR engagement facilitates effective disease resolution and response to monoclonal antibody immunotherapy. The underlying genetics of the FcγR gene family are a central component of this careful balance. Complex in humans and generated through ancestral duplication events, here we review the evolution of the gene family in mammals, the potential importance of copy number, and functionally relevant single nucleotide polymorphisms, as well as discussing current approaches and limitations when exploring genetic variation in this region | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Fc receptors | |
| 650 | 4 | |a antibodies | |
| 650 | 4 | |a genetics | |
| 650 | 4 | |a immunotherapy | |
| 650 | 7 | |a Receptors, IgG |2 NLM | |
| 700 | 1 | |a Rose-Zerilli, Matthew J J |e verfasserin |4 aut | |
| 700 | 1 | |a Machado, Lee R |e verfasserin |4 aut | |
| 700 | 1 | |a Iriyama, Chisako |e verfasserin |4 aut | |
| 700 | 1 | |a Hollox, Edward J |e verfasserin |4 aut | |
| 700 | 1 | |a Cragg, Mark S |e verfasserin |4 aut | |
| 700 | 1 | |a Strefford, Jonathan C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Immunological reviews |d 1993 |g 268(2015), 1 vom: 24. Nov., Seite 6-24 |w (DE-627)NLM000337404 |x 1600-065X |7 nnns |
| 773 | 1 | 8 | |g volume:268 |g year:2015 |g number:1 |g day:24 |g month:11 |g pages:6-24 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/imr.12341 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 268 |j 2015 |e 1 |b 24 |c 11 |h 6-24 | ||